7,845 Results

Real world analysis of Invokana in type 2 diabetes published in Circulation.- Janssen Pharma.

 Added 13 hours ago

A new real-world analysis of adults with type 2 diabetes and established cardiovascular disease (CVD) shows adult patients who initiated...

Subgroup analysis of FLAURA data of Tagrisso in NSCLC shows specific patient group benefits.- AstraZeneca.

 Added 13 hours ago

AstraZeneca presented new data from a subgroup analysis of the Phase III FLAURA trial, which explored Tagrisso (osimertinib) as 1st-line...

Global AF Awareness Week 2017

 Added 13 hours ago

Global AF Awareness Week 2017

Today starts the Awareness Week for Atrial Fibrillation.

Two analyses show benefits of Xarelto for patients with PAD and CAD.- Bayer + Janssen.

 Added 1 day ago

Two new analyses of data from the COMPASS trial show that Xarelto (rivaroxaban),from Bayer and Janssen ,significantly cut the amputation...

Acorda Therapeutics increases blood cell monitoring in Phase III programme for tozadenant for Parkinson’s disease.

 Added 1 day ago

Acorda Therapeutics, Inc. announced that it has increased the frequency of blood cell count monitoring for participants to weekly in...

FDA approves remote programming via telemedicine of Nucleus Cochlear Implant System.- Cochlear Corporation.

 Added 1 day ago

The FDA has approved a remote feature for follow-up programming sessions for the Nucleus Cochlear Implant System, from Cochlear Corporation,...

FDA approves Sutent to treat high risk patients post surgery with renal cell carcinoma

 Added 2 days ago

The FDA has approved Sutent (sunitinib malate) for the adjuvant treatment of adult patients who are at a high risk of kidney cancer (renal cell carcinoma) returning after a kidney has been removed (nephrectomy).

Trelegy Ellipta triple therapy meets EU approval for COPD

 Added 3 days ago

GlaxoSmithKline plc and Innoviva, Inc. announced that the European Commission has granted marketing authorisation for Trelegy Ellipta (fluticasone furoate/umeclidinium/vilanterol, ‘FF/UMEC/VI’)...

World Pancreatic Cancer Day 2017

 Added 4 days ago

World Pancreatic Cancer Day 2017

The organisers of World Pancreatic Cancer Day 2017 are asking us to Demand better.

Trial analysis presented at the American Heart Association (AHA) shows Lixiana has greater reductions in ischaemic events compared to warfarin

 Added 4 days ago

Sub analysis of ENGAGE AF-TIMI 48 trial showed Lixiana has greater reductions in ischaemic events compared to warfarin.

Load more